The FBN2 gene is hypermethylated in CRC tissue and serum samples from patients with CRC and liver metastases, and its expression is directly correlated with shorter survival rates in colon cancer patients, suggesting a possible role as a tumor suppressor gene (Leygo et al., 2017; Wang et al., 2022). This evidence concerns the gene FBN2 and colorectal carcinoma.